HEADER TRANSFERASE/TRANSFERASE INHIBITOR 16-JUN-14 4QMX TITLE MST3 IN COMPLEX WITH SARACATINIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE 24; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 1-303; COMPND 5 SYNONYM: STE20-LIKE KINASE MST3, MST-3, MAMMALIAN STE20-LIKE PROTEIN COMPND 6 KINASE 3; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: STK24, MST3, STK3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3) RIL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS PROTEIN KINASE, MST3, STK24, STERILE 20-LIKE KINASE, ATP-BINDING, KEYWDS 2 NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-TRANSFERASE, KEYWDS 3 TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.H.OLESEN,C.WATTS,J.-Y.ZHU,E.SCHONBRUNN REVDAT 6 09-OCT-24 4QMX 1 REMARK REVDAT 5 20-SEP-23 4QMX 1 REMARK SEQADV LINK REVDAT 4 11-APR-18 4QMX 1 REMARK REVDAT 3 13-JUL-16 4QMX 1 JRNL REVDAT 2 15-JUN-16 4QMX 1 JRNL REVDAT 1 01-JUL-15 4QMX 0 JRNL AUTH S.H.OLESEN,J.Y.ZHU,M.P.MARTIN,E.SCHONBRUNN JRNL TITL DISCOVERY OF DIVERSE SMALL-MOLECULE INHIBITORS OF MAMMALIAN JRNL TITL 2 STERILE20-LIKE KINASE 3 (MST3). JRNL REF CHEMMEDCHEM V. 11 1137 2016 JRNL REFN ISSN 1860-7179 JRNL PMID 27135311 JRNL DOI 10.1002/CMDC.201600115 REMARK 2 REMARK 2 RESOLUTION. 1.88 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8.4_1496) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.88 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.49 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 3 NUMBER OF REFLECTIONS : 21430 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.179 REMARK 3 FREE R VALUE : 0.219 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.980 REMARK 3 FREE R VALUE TEST SET COUNT : 1151 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 34.4974 - 3.7632 1.00 2889 150 0.1509 0.1916 REMARK 3 2 3.7632 - 2.9875 0.99 2812 150 0.1791 0.2010 REMARK 3 3 2.9875 - 2.6100 0.98 2757 147 0.2020 0.2553 REMARK 3 4 2.6100 - 2.3714 0.98 2765 140 0.2005 0.2259 REMARK 3 5 2.3714 - 2.2015 0.97 2717 149 0.1838 0.2251 REMARK 3 6 2.2015 - 2.0717 0.97 2706 144 0.1804 0.2106 REMARK 3 7 2.0717 - 1.9679 0.96 2682 132 0.1909 0.2658 REMARK 3 8 1.9679 - 1.8823 0.93 2613 139 0.2227 0.2970 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.210 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.520 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 2397 REMARK 3 ANGLE : 1.091 3241 REMARK 3 CHIRALITY : 0.043 355 REMARK 3 PLANARITY : 0.005 406 REMARK 3 DIHEDRAL : 16.578 918 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4QMX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-JUN-14. REMARK 100 THE DEPOSITION ID IS D_1000086256. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-NOV-12 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178 REMARK 200 MONOCHROMATOR : MIRRORS REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944+ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22568 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.04700 REMARK 200 FOR THE DATA SET : 42.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.93 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.23300 REMARK 200 FOR SHELL : 8.760 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: PDB ENTRY 3CKW REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.70 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.11 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12.5 MG/ML MST3, 1 MM SARACATINIB,25 REMARK 280 MM TRIS, PH 8.0, 50 MM HEPES PH 7.5, 125 MM SODIUM, CHLORIDE, REMARK 280 100 MM MAGNESIUM CHLORIDE, 15% PEG 400, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 27.55950 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: MONOMER PER ASU REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -6 REMARK 465 PRO A -5 REMARK 465 LEU A -4 REMARK 465 GLY A -3 REMARK 465 SER A -2 REMARK 465 GLU A -1 REMARK 465 PHE A 0 REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 HIS A 3 REMARK 465 SER A 4 REMARK 465 PRO A 5 REMARK 465 VAL A 6 REMARK 465 GLN A 7 REMARK 465 SER A 8 REMARK 465 GLY A 9 REMARK 465 LEU A 10 REMARK 465 PRO A 11 REMARK 465 HIS A 300 REMARK 465 ASP A 301 REMARK 465 ASP A 302 REMARK 465 SER A 303 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 27 -148.94 -108.39 REMARK 500 SER A 34 -41.87 63.55 REMARK 500 ASP A 92 -117.06 55.90 REMARK 500 ASP A 144 46.80 -143.21 REMARK 500 ASP A 162 85.66 60.05 REMARK 500 ASP A 197 -149.18 -141.88 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE H8H A 401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4QML RELATED DB: PDB REMARK 900 RELATED ID: 4QMM RELATED DB: PDB REMARK 900 RELATED ID: 4QMN RELATED DB: PDB REMARK 900 RELATED ID: 4QMO RELATED DB: PDB REMARK 900 RELATED ID: 4QMP RELATED DB: PDB REMARK 900 RELATED ID: 4QMQ RELATED DB: PDB REMARK 900 RELATED ID: 4QMR RELATED DB: PDB REMARK 900 RELATED ID: 4QMS RELATED DB: PDB REMARK 900 RELATED ID: 4QMT RELATED DB: PDB REMARK 900 RELATED ID: 4QMV RELATED DB: PDB REMARK 900 RELATED ID: 4QMW RELATED DB: PDB REMARK 900 RELATED ID: 4QMX RELATED DB: PDB REMARK 900 RELATED ID: 4QMZ RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CRYSTALLIZED SEQUENCE REFERS TO THE ISOFORM A DBREF 4QMX A 1 303 UNP Q9Y6E0 STK24_HUMAN 1 303 SEQADV 4QMX GLY A -6 UNP Q9Y6E0 EXPRESSION TAG SEQADV 4QMX PRO A -5 UNP Q9Y6E0 EXPRESSION TAG SEQADV 4QMX LEU A -4 UNP Q9Y6E0 EXPRESSION TAG SEQADV 4QMX GLY A -3 UNP Q9Y6E0 EXPRESSION TAG SEQADV 4QMX SER A -2 UNP Q9Y6E0 EXPRESSION TAG SEQADV 4QMX GLU A -1 UNP Q9Y6E0 EXPRESSION TAG SEQADV 4QMX PHE A 0 UNP Q9Y6E0 EXPRESSION TAG SEQRES 1 A 310 GLY PRO LEU GLY SER GLU PHE MET ALA HIS SER PRO VAL SEQRES 2 A 310 GLN SER GLY LEU PRO GLY MET GLN ASN LEU LYS ALA ASP SEQRES 3 A 310 PRO GLU GLU LEU PHE THR LYS LEU GLU LYS ILE GLY LYS SEQRES 4 A 310 GLY SER PHE GLY GLU VAL PHE LYS GLY ILE ASP ASN ARG SEQRES 5 A 310 THR GLN LYS VAL VAL ALA ILE LYS ILE ILE ASP LEU GLU SEQRES 6 A 310 GLU ALA GLU ASP GLU ILE GLU ASP ILE GLN GLN GLU ILE SEQRES 7 A 310 THR VAL LEU SER GLN CYS ASP SER PRO TYR VAL THR LYS SEQRES 8 A 310 TYR TYR GLY SER TYR LEU LYS ASP THR LYS LEU TRP ILE SEQRES 9 A 310 ILE MET GLU TYR LEU GLY GLY GLY SER ALA LEU ASP LEU SEQRES 10 A 310 LEU GLU PRO GLY PRO LEU ASP GLU THR GLN ILE ALA THR SEQRES 11 A 310 ILE LEU ARG GLU ILE LEU LYS GLY LEU ASP TYR LEU HIS SEQRES 12 A 310 SER GLU LYS LYS ILE HIS ARG ASP ILE LYS ALA ALA ASN SEQRES 13 A 310 VAL LEU LEU SER GLU HIS GLY GLU VAL LYS LEU ALA ASP SEQRES 14 A 310 PHE GLY VAL ALA GLY GLN LEU THR ASP THR GLN ILE LYS SEQRES 15 A 310 ARG ASN TPO PHE VAL GLY THR PRO PHE TRP MET ALA PRO SEQRES 16 A 310 GLU VAL ILE LYS GLN SER ALA TYR ASP SER LYS ALA ASP SEQRES 17 A 310 ILE TRP SER LEU GLY ILE THR ALA ILE GLU LEU ALA ARG SEQRES 18 A 310 GLY GLU PRO PRO HIS SER GLU LEU HIS PRO MET LYS VAL SEQRES 19 A 310 LEU PHE LEU ILE PRO LYS ASN ASN PRO PRO THR LEU GLU SEQRES 20 A 310 GLY ASN TYR SER LYS PRO LEU LYS GLU PHE VAL GLU ALA SEQRES 21 A 310 CYS LEU ASN LYS GLU PRO SER PHE ARG PRO THR ALA LYS SEQRES 22 A 310 GLU LEU LEU LYS HIS LYS PHE ILE LEU ARG ASN ALA LYS SEQRES 23 A 310 LYS THR SER TYR LEU THR GLU LEU ILE ASP ARG TYR LYS SEQRES 24 A 310 ARG TRP LYS ALA GLU GLN SER HIS ASP ASP SER MODRES 4QMX TPO A 178 THR PHOSPHOTHREONINE HET TPO A 178 11 HET H8H A 401 38 HETNAM TPO PHOSPHOTHREONINE HETNAM H8H N-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-7-[2-(4- HETNAM 2 H8H METHYLPIPERAZIN-1-YL)ETHOXY]-5-(TETRAHYDRO-2H-PYRAN-4- HETNAM 3 H8H YLOXY)QUINAZOLIN-4-AMINE HETSYN TPO PHOSPHONOTHREONINE HETSYN H8H SARACATINIB FORMUL 1 TPO C4 H10 N O6 P FORMUL 2 H8H C27 H32 CL N5 O5 FORMUL 3 HOH *163(H2 O) HELIX 1 1 PRO A 20 GLU A 22 5 3 HELIX 2 2 GLU A 63 GLN A 76 1 14 HELIX 3 3 ALA A 107 GLU A 112 1 6 HELIX 4 4 ASP A 117 GLU A 138 1 22 HELIX 5 5 LYS A 146 ALA A 148 5 3 HELIX 6 6 THR A 182 MET A 186 5 5 HELIX 7 7 ALA A 187 LYS A 192 1 6 HELIX 8 8 SER A 198 GLY A 215 1 18 HELIX 9 9 HIS A 223 ASN A 234 1 12 HELIX 10 10 SER A 244 LEU A 255 1 12 HELIX 11 11 GLU A 258 ARG A 262 5 5 HELIX 12 12 THR A 264 LEU A 269 1 6 HELIX 13 13 HIS A 271 ALA A 278 1 8 HELIX 14 14 LYS A 280 TYR A 283 5 4 HELIX 15 15 LEU A 284 GLN A 298 1 15 SHEET 1 A 6 LYS A 17 ALA A 18 0 SHEET 2 A 6 TYR A 85 LYS A 91 1 O LEU A 90 N LYS A 17 SHEET 3 A 6 LYS A 94 GLU A 100 -1 O TRP A 96 N TYR A 89 SHEET 4 A 6 VAL A 49 ASP A 56 -1 N ALA A 51 O MET A 99 SHEET 5 A 6 GLU A 37 ASP A 43 -1 N PHE A 39 O ILE A 52 SHEET 6 A 6 PHE A 24 LYS A 32 -1 N ILE A 30 O VAL A 38 SHEET 1 B 3 GLY A 105 SER A 106 0 SHEET 2 B 3 VAL A 150 LEU A 152 -1 O LEU A 152 N GLY A 105 SHEET 3 B 3 VAL A 158 LEU A 160 -1 O LYS A 159 N LEU A 151 SHEET 1 C 2 LYS A 140 ILE A 141 0 SHEET 2 C 2 GLY A 167 GLN A 168 -1 O GLY A 167 N ILE A 141 LINK C ASN A 177 N TPO A 178 1555 1555 1.33 LINK C TPO A 178 N PHE A 179 1555 1555 1.33 SITE 1 AC1 13 ILE A 30 LYS A 32 VAL A 38 ALA A 51 SITE 2 AC1 13 LYS A 53 GLU A 70 ILE A 97 MET A 99 SITE 3 AC1 13 GLU A 100 TYR A 101 LEU A 102 GLY A 103 SITE 4 AC1 13 HOH A 574 CRYST1 47.551 55.119 60.640 90.00 111.58 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021030 0.000000 0.008316 0.00000 SCALE2 0.000000 0.018143 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017733 0.00000